NURSING DOMAIN
Published June 25, 2025 | Version v1
Journal article Open

Histo Pathology, Diagnosis, Differential Diagnosis, Treatment, Prognosis and Complications of Herpes Simplex Virus Type - 2

Creators

Description

This exercise highlights the role of the primary care physician in managing patients with herpes simplex type 2 and provides information on how to evaluate and treat the condition. This study will organize fundamental information about herpes genitalis and its clinical manifestations, as well as important facets of prophylactic, antiviral therapy (both present and future), and diagnostic procedures. This exercise focuses on the interprofessional team that treats patients with genital herpes and the risk of contracting the disease.

 

Files

Histo Pathology, Diagnosis, Differential Diagnosis, Treatment -Formatted Paper.pdf

Files (336.1 kB)

Additional details

References

  • 1. Workowski, K. A., Bolan, G. A., & Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(RR-03), 1–137. https://www.cdc.gov/std/tg2015/default.htm
  • 2. Whitley, R., & Baines, J. (2018). Clinical management of herpes simplex virus infections: Past, present, and future. F1000Research, 7, 1721. https://doi.org/10.12688/f1000research.16048.1
  • 3. Sauerbrei, A. (2016). Herpes genitalis: Diagnosis, treatment and prevention. Geburtshilfe und Frauenheilkunde, 76(12), 1310–1317. https://doi.org/10.1055/s-0042-117493
  • 4. Fleming, D. T., Leone, P., Esposito, D., Heitman, C. K., Justus, S., Chin, S., & Fife, K. H. (2006). Herpes virus type 2 infection and genital symptoms in primary care patients. Sexually Transmitted Diseases, 33(7), 416–421. https://doi.org/10.1097/01.olq.0000204710.04638.92
  • 5. Anzivino, E., Fioriti, D., Mischitelli, M., Bellizzi, A., Barucca, V., Chiarini, F., & Pietropaolo, V. (2009). Herpes simplex virus infection in pregnancy and in neonate: Status of art of epidemiology, diagnosis, therapy and prevention. Virology Journal, 6, 40. https://doi.org/10.1186/1743-422X-6-40
  • 6. Bradley, H., Markowitz, L. E., Gibson, T., & McQuillan, G. M. (2014). Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. Journal of Infectious Diseases, 209(3), 325–333. https://doi.org/10.1093/infdis/jit458
  • 7. Centers for Disease Control and Prevention. (2010). Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years—United States, 2005–2008. Morbidity and Mortality Weekly Report, 59(15), 456–459.
  • 8. Berger, J. R., & Houff, S. (2008). Neurological complications of herpes simplex virus type 2 infection. Archives of Neurology, 65(5), 596–600. https://doi.org/10.1001/archneur.65.5.596
  • 9. Fatahzadeh, M., & Schwartz, R. A. (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737–763. https://doi.org/10.1016/j.jaad.2007.06.020
  • 10. Leinweber, B., Kerl, H., & Cerroni, L. (2006). Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): A broad spectrum of presentations with common pseudolymphomatous aspects. American Journal of Surgical Pathology, 30(1), 50–58. https://doi.org/10.1097/01.pas.0000176435.37734.64